Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)
Price and Volume
Detailed Quote| Volume | 601,543 |
| Open | 101.75 |
| Bid (Size) | 96.17 (100) |
| Ask (Size) | 125.00 (700) |
| Prev. Close | 100.31 |
| Today's Range | 100.53 - 104.95 |
| 52wk Range | 36.65 - 130.05 |
| Shares Outstanding | 55,307,775 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
These stocks are gapping in today's session ↗
June 25, 2026
Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗
February 23, 2026
Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗
January 01, 2026
Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗
December 09, 2025
Frequently Asked Questions
Is Kymera Therapeutics, Inc. - Common Stock publicly traded?
Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?
Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?
The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market
What is the current price of Kymera Therapeutics, Inc. - Common Stock?
The current price of Kymera Therapeutics, Inc. - Common Stock is 104.39
When was Kymera Therapeutics, Inc. - Common Stock last traded?
The last trade of Kymera Therapeutics, Inc. - Common Stock was at 08/04/26 04:00 PM ET
What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?
The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 5.77B
How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?
Kymera Therapeutics, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.